Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin
- 1 October 1973
- Vol. 32 (4), 756-760
- https://doi.org/10.1002/1097-0142(197310)32:4<756::aid-cncr2820320404>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Triple combination chemotherapy of disseminated melanomaCancer, 1972
- 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanomaEuropean Journal of Cancer (1965), 1972
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanomaClinical Pharmacology & Therapeutics, 1971
- Improved systemic chemotherapy for malignant melanomaThe American Journal of Surgery, 1971
- Imidazole carboxamide therapy in advanced malignant melanomaCancer, 1971
- Intra-arterial therapy of melanoma with dimethyl triazeno imidazole carboxamide (NSC-45388)Cancer, 1971
- Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumorsCancer, 1969
- Induced remission of malignant melanoma with actinomycin D.Immunologic implicationsCancer, 1967
- Combination Therapy of Adult Acute Myelogenous LeukemiaNew England Journal of Medicine, 1965
- Effects of Combined Drug Therapy on Metastatic Cancer of the TestisJAMA, 1960